The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -0.59% | -2.55% | -4.70% | 0.14% | 17.65% | 18.60% |
| Abbott India | -0.25% | -0.27% | -6.89% | -1.12% | -6.71% | -17.47% |
| Anthem Bioscienc | 0.26% | -1.44% | -2.70% | 18.58% | 14.91% | 5.24% |
| Ipca Labs. | -0.45% | -4.28% | -6.21% | 0.12% | 9.48% | 13.33% |
| Glaxosmi. Pharma | 0.05% | 4.39% | -8.13% | -9.86% | -14.00% | -33.18% |
| Gland Pharma | 0.72% | -4.73% | 1.73% | 32.05% | 31.85% | 26.71% |
| J B Chemicals & | 0.41% | -2.47% | 3.36% | 3.81% | 22.99% | 27.77% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & Company Secretary : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal